Abstract:Background: Emerging evidence indicates that reactive microglia-initiated inflammatory responses are responsible for secondary damage after primary traumatic spinal cord injury (SCI); epidermal growth factor receptor (EGFR) signaling may be involved in cell activation. In this report, we investigate the influence of EGFR signaling inhibition on microglia activation, proinflammatory cytokine production, and the neuronal microenvironment after SCI. Methods: Lipopolysaccharide-treated primary microglia/BV2 line cells and SCI rats were used as model systems. Both C225 and AG1478 were used to inhibit EGFR signaling activation. Cell activation and EGFR phosphorylation were observed after fluorescent staining and western blot. Production of interleukin-1 beta (IL-1 β) and tumor necrosis factor alpha (TNF α) was tested by reverse transcription PCR and ELISA. Western blot was performed to semi-quantify the expression of EGFR/phospho-EGFR, and phosphorylation of Erk, JNK and p38 mitogen-activated protein kinases (MAPK). Wet-dry weight was compared to show tissue edema. Finally, axonal tracing and functional scoring were performed to show recovery of rats. Results: EGFR phosphorylation was found to parallel microglia activation, while EGFR blockade inhibited activation-associated cell morphological changes and production of IL-1 β and TNF α. EGFR blockade significantly downregulated the elevated MAPK activation after cell activation; selective MAPK inhibitors depressed production of cytokines to a certain degree, suggesting that MAPK mediates the depression of microglia activation brought about by EGFR inhibitors. Subsequently, seven-day continual infusion of C225 or AG1478 in rats: reduced the expression of phospho-EGFR, phosphorylation of Erk and p38 MAPK, and production of IL-1 β and TNF α; lessened neuroinflammation-associated secondary damage, like microglia/astrocyte activation, tissue edema and glial scar/cavity formation; and enhanced axonal outgrowth and functional recovery. Conclusions: These findings indicate that inhibition of EGFR/MAPK suppresses microglia activation and associated cytokine production; reduces neuroinflammation-associated secondary damage, thus provides neuroprotection to SCI rats, suggesting that EGFR may be a therapeutic target, and C225 and AG1478 have potential for use in SCI treatment.

Epidermal Growth Factor Receptor Signaling Pathway Activation Mediating Inflammatory Damage in Central Nervous System

Molecular Mechanisms of Activated Epidermal Growth Factor Receptor Signaling Pathway Mediating Blood Spinal Cord Barrier Damage after Spinal Cord Injury

Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury

Different epidermal growth factor receptor signaling pathways in neurons and astrocytes activated by extracellular matrix after spinal cord injury

Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury

Neuron and Microglia/macrophage-Derived FGF10 Activate Neuronal FGFR2/PI3K/Akt Signaling and Inhibit Microglia/macrophages TLR4/NF-κB-dependent Neuroinflammation to Improve Functional Recovery after Spinal Cord Injury.

Epidermal Growth Factor Attenuates Blood-Spinal Cord Barrier Disruption Via Pi3k/Akt/Rac1 Pathway after Acute Spinal Cord Injury

Epidermal Growth Factor Receptor Activation: an Upstream Signal for Transition of Quiescent Astrocytes into Reactive Astrocytes after Neural Injury

Activation of the Epac/Rap1 signaling pathway alleviates blood-brain barrier disruption and brain damage following cerebral ischemia/reperfusion injury

Blocking Epidermal Growth Factor Receptor Attenuates Reactive Astrogliosis Through Inhibiting Cell Cycle Progression and Protects Against Ischemic Brain Injury in Rats.

Roles of Eph/ephrin Bidirectional Signaling in Central Nervous System Injury and Recovery (Review)

Epidermal Growth Factor Receptor-Extracellular-regulated Kinase Blockade Upregulates TRIM32 Signaling Cascade and Promotes Neurogenesis after Spinal Cord Injury

Involvement of early growth response-2 (Egr-2) in lipopolysaccharide-induced neuroinflammation

Upregulation of EphA4 deteriorate brain damage by shifting microglia M1-polarization via NF-κB signaling after focal cerebral ischemia in rats

A Causal Relationship in Spinal Cord Injury Rat Model Between Microglia Activation and EGFR/MAPK Detected by Overexpression of MicroRNA-325-3p

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.

Brain-to-cervical lymph node signaling after stroke

Roles of Extra-Cellular Signal-Regulated Protein Kinase 5 Signaling Pathway in the Development of Spinal Cord Injury.

CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade Across Schwann Cell-Neuron-Microglia.

Myelin Activates Fak/Akt/Nf-Kappa B Pathways and Provokes Cr3-Dependent Inflammatory Response in Murine System

Inflammation and Immune Cell Abnormalities in Intracranial Aneurysm Subarachnoid Hemorrhage (SAH): Relevant Signaling Pathways and Therapeutic Strategies